Compugen (CGEN) Assets Growth (1y) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.15% |
| Sep 30, 2025 | -20.78% |
| Jun 30, 2025 | -3.31% |
| Mar 31, 2025 | 1.53% |
| Dec 31, 2024 | -5.22% |
| Sep 30, 2024 | 82.69% |
| Jun 30, 2024 | 42.97% |
| Mar 31, 2024 | 34.85% |
| Dec 31, 2023 | 28.84% |
| Sep 30, 2023 | -31.96% |
| Jun 30, 2023 | -30.15% |
| Mar 31, 2023 | -30.28% |
| Dec 31, 2022 | -28.74% |
| Sep 30, 2022 | -18.08% |
| Jun 30, 2022 | -10.18% |
| Mar 31, 2022 | -6.96% |
| Dec 31, 2021 | -4.45% |
| Sep 30, 2021 | -15.39% |
| Jun 30, 2021 | -15.83% |
| Mar 31, 2021 | -0.89% |
| Dec 31, 2020 | 157.27% |
| Sep 30, 2020 | 150.06% |
| Jun 30, 2020 | 202.33% |
| Mar 31, 2020 | 157.73% |
| Dec 31, 2019 | 1.10% |
| Sep 30, 2019 | 12.36% |
| Jun 30, 2019 | -5.43% |
| Mar 31, 2019 | 30.25% |
| Dec 31, 2018 | 37.25% |
| Sep 30, 2018 | 8.35% |
| Jun 30, 2018 | -8.24% |
| Mar 31, 2018 | -39.13% |
| Dec 31, 2017 | -45.53% |
| Sep 30, 2017 | -39.56% |
| Jun 30, 2017 | -34.14% |
| Mar 31, 2017 | -29.78% |
| Dec 31, 2016 | -28.36% |
| Sep 30, 2016 | -19.75% |
| Jun 30, 2016 | -18.20% |
| Mar 31, 2016 | -15.74% |
| Dec 31, 2015 | -13.64% |
| Sep 30, 2015 | -15.32% |
| Jun 30, 2015 | -15.04% |
| Mar 31, 2015 | -13.73% |
| Dec 31, 2014 | 102.76% |
| Sep 30, 2014 | 106.97% |
| Jun 30, 2014 | 228.44% |
| Mar 31, 2014 | 273.88% |
| Dec 31, 2013 | 96.17% |
| Sep 30, 2013 | 97.34% |
| Jun 30, 2013 | 23.40% |
| Mar 31, 2013 | 3.50% |
| Dec 31, 2012 | -0.59% |
| Sep 30, 2012 | -1.59% |
| Jun 30, 2012 | -6.80% |
| Mar 31, 2012 | -5.61% |
| Dec 31, 2011 | -20.23% |
| Sep 30, 2011 | -3.86% |
| Jun 30, 2011 | 11.13% |
| Mar 31, 2011 | 8.55% |
| Dec 31, 2010 | 20.78% |
| Sep 30, 2010 | 146.70% |
| Jun 30, 2010 | 114.33% |
| Mar 31, 2010 | 169.26% |